|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/351 | |
| A61P 35/00 | |||
| A61K 33/26 | |||
| A61P 1/04 | |||
| A61P 3/02 | |||
| A61P 43/00 | |||
| A61P 7/06 |
| (11) | Patento numeris | 3435999 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17714766.7 |
| Europos patento paraiškos padavimo data | 2017-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/057705 |
| Data | 2017-03-31 |
| (87) | Numeris | WO 2017/167972 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 201605474 | 2016-03-31 | GB |
| (72) |
POWELL, Jonathan, Joseph, GB
PEREIRA, Dora, I.A., GB
|
| (73) |
Shield TX (UK) Limited,
Northern Design Centre Baltic Business Quarter Gateshead Tyne And Wear, NE8 3DF,
GB
|
| (54) | FERRIC MALTOL COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER AND TUMOURS |
| FERRIC MALTOL COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER AND TUMOURS |